OrbiMed provides Intellia Therapeutics with up to $400m senior secured term loan
Intellia drew $75 million at closing under the five-year facility, which matures on 4 September 2031.
2 min read7 Sept 2026Individual financings — raised, refinanced, extended — and the terms behind them.
Intellia drew $75 million at closing under the five-year facility, which matures on 4 September 2031.
2 min read7 Sept 2026The debt facility forms part of a $200 million Series C package for the Miami WhatsApp remittance fintech, alongside $87 million of equity led by Andreessen Horowitz.
1 min read4 Sept 2026The Accelmed-backed neurorehabilitation company drew $10 million at close, with a further $5 million available, and said the capital will support product expansion.
1 min read3 Sept 2026The capital will fund Z4 technology maturation, Jet1 demonstrator manufacturing and Factory1 in Greensboro, as California's JetZero develops its all-wing airliner.
2 min read1 Sept 2026The facilities sit in a $220 million combined close that includes a $90 million Series C led by Noteus Partners, as the London-founded imaging network expands in the United States.
2 min read31 Aug 2026The Irvine, California company sells cloud-native warehouse management software to businesses and third-party logistics providers.
2 min read31 Aug 2026The Massachusetts payments company will use the capital as working capital to support growth and to refinance existing debt.
1 min read31 Aug 2026The Massachusetts company sells a vendor-agnostic Wireless Intelligence Platform that combines on-site sensors with cloud software to monitor enterprise Wi-Fi.
2 min read28 Aug 2026The Michigan based company will use the commitment to expand manufacturing of its insulation technology for buildings.
2 min read28 Aug 2026The South Jordan, Utah company sells contact-centre software to mid-market operators in healthcare, financial services, field services and transportation.
2 min read28 Aug 2026